doi:10.3390/jcm12030772 Share this: Share on X (Opens in new window) X Discover more from Sarah Hormachea Subscribe to get the latest posts sent to your email.
These findings led to changes in clinical practice guidelines modern diabetes guidelines recommend GLP-1 agonists (or related drugs) for patients with type 2 diabetes who have cardiovascular risk, and even suggest using a GLP-1 RA prior to insulin in many cases due to their multiple benefits and weight loss advantage ( [10] ) ( [11] )
Other conditions showing signals Emerging research suggests potential benefit in gout (reduced risk of development in GLP-1 users), osteoarthritis (improved joint outcomes in semaglutide users), and endometriosis (anti-inflammatory mechanisms relevant to endometrial inflammation)
In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G (eds) The online metabolic and molecular bases of inherited disease, McGraw-Hill, New York
Glutathione and Skin Radiance Of all the topics in this guide, this is the one where marketing has done the most damage to honest medical communication